1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression.
about
1,25 Dihydroxyvitamin D3 Inhibits TGFβ1-Mediated Primary Human Cardiac Myofibroblast ActivationVitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adultsMultiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung CancerParicalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 productionVitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolismNuclear receptors in renal diseasePreventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.Pathogenesis of Systemic Sclerosis.Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1Vitamin D Attenuates Kidney Fibrosis via Reducing Fibroblast Expansion, Inflammation, and Epithelial Cell ApoptosisTissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signalingPreventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis.Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signalingTherapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosisVitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors.Vitamin D receptor as a therapeutic target for benign prostatic hyperplasiaInteraction of vitamin D with membrane-based signaling pathwaysEffects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review.The emerging role of hepatocyte growth factor in renal diseases.Signaling Crosstalk between Tubular Epithelial Cells and Interstitial Fibroblasts after Kidney Injury.Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction.Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells.Low vitamin D status in systemic sclerosis and the impact on disease phenotype22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.Vitamin D attenuates myofibroblast differentiation and extracellular matrix accumulation in nasal polyp-derived fibroblasts through smad2/3 signaling pathway.1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss.1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition.Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease.A nonclassical vitamin D receptor pathway suppresses renal fibrosis.Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma.Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?Vitamin D receptor: A novel therapeutic target for kidney diseases.Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1.Histoprotective effect of vitamin D against carbon tetrachloride nephrotoxicity in rats.Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.
P2860
Q28548048-4C7ADDA9-312D-4FF0-824C-4684DB7B11F0Q33657136-8FFE36DF-8CF6-459B-8F49-B828B278AE78Q33748259-39A10A42-510B-4A07-833A-515651079C49Q34287169-8E91E47E-6B83-4534-B4F6-87AEEACA89E7Q34719267-A452D1D3-62DA-43C5-BC0A-B0D8FE538616Q35120702-3F16852F-97F6-4812-8F8E-3688311087C6Q35167070-67E6E7DB-5166-4AE7-8765-A3CE8FF7A4A7Q35693212-C51BD5F1-71F5-4157-B8C3-6497ECCEE7C4Q36101672-EF72366F-C898-45BE-B3BB-C4CB06137DDCQ36117933-E08A36A7-03C4-46A7-9912-09CFF8E9C114Q36151652-CB26C0C5-DCA6-40E2-895C-BA97DAEEF6D7Q36340289-A7DBC045-24B8-459A-AA58-3F5F16D5F67BQ36787402-B6F9C3C9-B289-454A-85CA-01AF433B9ECBQ36842418-4817AF25-E429-4C0E-9C18-0213B97C078EQ37141825-47B7A85E-0053-49E1-BEE0-7DEAC6C88760Q37155210-2F123862-956F-4298-9585-73450058D763Q37186311-2E61631C-6317-4793-92C7-108A550BB0D3Q38085581-2A829681-615C-4E80-8D16-321B23FF4A51Q38193801-DDE43A27-5CFC-44E9-AB7A-1F954FC9B6FCQ38228157-2E137CD9-4401-4802-A9F3-6F7C74DA517EQ38605788-141E38B5-A35C-4A80-91DA-76FD45615058Q39030259-490DA6B1-3641-43C5-A248-08D32B04F31EQ39536409-BFC89AD5-78B8-476A-8503-F5C1C8C74CA3Q39770504-5A58A8D0-9CD1-4BBA-A922-C7C2E1613D6BQ39772110-93AE4EFF-B7B9-4207-A8AB-5A14CACCB22EQ40410753-660DD97F-46F7-4B5F-BFED-B6F5F8F5BC72Q41105771-297B221D-C798-45EF-8F73-1D1387CCD4DBQ41260549-72F3D693-6B6F-4970-96CE-69B12FD3295DQ41897679-73088E20-8D2C-424B-8ADC-17EAA4366BECQ41902905-80897187-4FD2-46C8-9DAC-55A0FB6866BAQ42429155-0FB970A0-0FDE-4B0B-9D89-27784E6927F5Q42932434-A5A982D3-3F47-4E33-A1F8-198131B4E0D5Q44901896-9E3F252A-BCFA-42EA-97D6-B7B4BE5F73EEQ48345496-7CCB9931-CD83-4E25-9B4A-5CABF88A59E7Q49985993-4D16C847-CC6E-49E7-8702-83EB37285FACQ51334626-E52EA832-FF25-4782-A535-CBA4B0D8A2E3Q52923000-0D1CD28C-1CD4-40D3-BBC6-836C3EBBC438Q54642763-72ACF420-6CBE-4874-BB09-3392E3B5B420
P2860
1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
1,25-dihydroxyvitamin D inhibi ...... cyte growth factor expression.
@en
type
label
1,25-dihydroxyvitamin D inhibi ...... cyte growth factor expression.
@en
prefLabel
1,25-dihydroxyvitamin D inhibi ...... cyte growth factor expression.
@en
P2093
P1433
P1476
1,25-dihydroxyvitamin D inhibi ...... cyte growth factor expression.
@en
P2093
Bradley C Spataro
Chunsun Dai
Junwei Yang
Yingjian Li
Youhua Liu
P304
P356
10.1111/J.1523-1755.2005.00562.X
P407
P577
2005-10-01T00:00:00Z
P5875
P6179
1007337099